We hypothesised that hyperamylinaemia gives rise to ligand-mediated amylin resistance in the brain, leading to changes in the expression of metabolic genes that drive hyperphagia, subsequent obesity and insulin resistance. This evidence concerns the gene IAPP and Insulin resistance.